UseGrants

Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)

National Institutes of HealthAmount not specifiedNo deadline listedForecasted
View on Grants.gov →

This is a forecasted opportunity — a pre-announcement that isn’t open for applications yet. Dates and details may change before it posts.

This NIH forecast announces a planned SBIR Phase IIB Bridge Award opportunity to help small businesses accelerate cancer-relevant technologies toward commercialization. It is restricted to small bu…

Deadline
Not specified
Posted
Jun 16, 2025
Award amount
Amount not specified

In plain English

This NIH forecast announces a planned SBIR Phase IIB Bridge Award opportunity to help small businesses accelerate cancer-relevant technologies toward commercialization. It is restricted to small businesses conducting SBIR-eligible cancer research; other applicant types are not eligible. As a forecast only, specific funding amounts and deadlines are not yet published.

AI-generated summary to help you decide quickly — verify the official eligibility rules before applying.

Let AI draft your application

Your first draft is free: a narrative and budget outline tailored to this grant, emailed to you. Drafts are written in a nightly batch, so it arrives by email later — not instantly on this page.

Application Kit — $49 one-time

Winner intelligence + a first-draft narrative grounded in applications that actually won. One payment, no subscription.

Get the Application Kit

Related grants

Other open grants from National Institutes of Health — soonest deadline first.

Also listed under National Institutes of Health.

Source: public records via Grants.gov. UseGrants is an independent aggregator, not affiliated with any funding agency. Always confirm details on the official listing before applying.